COVID-19-associated coagulopathy and thrombosis in cancer
During the 11th ICTHIC, Marcel M Levi talked about COVID-19 thrombotic implications in patients with cancer. Here, we...
Focus on: COVID-19
COVID-19 and Thrombosis in Cancer Patients: The Clot Thickens
March 2021 marks a full year since the WHO officially declared the coronavirus disease 2019 (COVID-19) outbreak a...
The European Independent Foundation in Angiology/Vascular: Guidance for patient management during the COVID-19 emergency
The European Independent Foundation in Angiology/Vascular Medicine is a non-profit, scientific foundation dedicated to...
COVID-19 Hemostasis and Malignancy: the Bergamo Experience
The COVID-19 pandemic took one of its biggest tolls on Italy, and especially in the northern area, in Lombardy. In this...
COVID-19 and Management of Thrombotic Disease
The coronavirus disease 2019 (COVID-19) pandemic has posed a series of new questions in management of patients....
Impact of COVID-19 on healthcare workers and health systems
After the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, the adoption of specific personal...
Prophylaxis for venous thromboembolism in COVID-19 Patients
The development of venous thromboembolism (VTE) is one of the major consequences observed in patients with Coronavirus...
Coagulopathy and thrombosis in COVID-19 patients: parameters to be checked to assess disease severity
As the clinical evidence keeps on accumulating, we can clearly state that coronavirus disease 2019 (COVID-19) very...
COVID-19 and hemostasis issues in cancer patients: an interview with Professor Khorana
The optimal clinical management of COVID-19 patients is largely debated, as well as the treatment aimed for a specific...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
The COVID-19 outbreak has now spread worldwide, and the number of severe cases is increasing exponentially. Besides the...